# Clinical Outcomes in Patients Treated With SternaLock Blu

> **NCT03709693** · — · TERMINATED · sponsor: **Zimmer Biomet** · enrollment: 156 (actual)

## Conditions studied

- Cardiac Surgical Procedures
- Coronary Artery Disease
- Heart Valve Diseases

## Interventions

- **DEVICE:** SternaLock Blu

## Key facts

- **NCT ID:** NCT03709693
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-14
- **Primary completion:** 2020-05-13
- **Final completion:** 2020-05-13
- **Target enrollment:** 156 (ACTUAL)
- **Why stopped:** COVID 19 Pandemic
- **Last updated:** 2021-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709693, "Clinical Outcomes in Patients Treated With SternaLock Blu". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03709693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*